Novozymes (NZM2) Stock Overview

Produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. More details

NZM2 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	3/6
Past Performance	3/6
Financial Health	5/6
Dividends	4/6

Rewards

Trading at 32.4% below our estimate of its fair value

Earnings are forecast to grow 17.09% per year

Earnings grew by 99.4% over the past year

Risk Analysis

Shares are highly illiquid

Large one-off items impacting financial results

Unstable dividend track record

NZM2 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View Stock Community

Novozymes A/S Competitors

Price History & Performance

Summary of share price highs, lows and changes for Novozymes
Historical stock prices
Current Share Price	DKK 52.34
52 Week High	DKK 54.60
52 Week Low	DKK 50.34
Beta	0.57
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	1,205.24%

Recent updates

Shareholder Returns

	NZM2	DE Chemicals	DE Market
7D	4.0%	2.9%	2.7%
1Y	n/a	-14.7%	14.6%

Return vs Industry: Insufficient data to determine how NZM2 performed against the German Chemicals industry.

Return vs Market: Insufficient data to determine how NZM2 performed against the German Market.

Price Volatility

Is NZM2's price volatile compared to industry and market?
NZM2 volatility
NZM2 Average Weekly Movement	n/a
Chemicals Industry Average Movement	4.3%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	12.3%
10% least volatile stocks in DE Market	2.5%

Stable Share Price: NZM2's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine NZM2's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1925	10,582	Ester Baiget	www.novonesis.com

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and early lie nutrition. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Novozymes A/S Fundamentals Summary

How do Novozymes's earnings and revenue compare to its market cap?
NZM2 fundamental statistics
Market cap	€24.39b
Earnings (TTM)	€564.70m
Revenue (TTM)	€4.10b

43.2x

P/E Ratio

6.0x

P/S Ratio

Is NZM2 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NZM2 income statement (TTM)
Revenue	€4.10b
Cost of Revenue	€1.73b
Gross Profit	€2.37b
Other Expenses	€1.80b
Earnings	€564.70m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Nov 06, 2025

Earnings per share (EPS)	1.21
Gross Margin	57.72%
Net Profit Margin	13.78%
Debt/Equity Ratio	30.9%

How did NZM2 perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

43%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/10/05 00:50
End of Day Share Price	2025/10/03 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Novozymes A/S is covered by 41 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Michael Vitfell-Rasmussen	ABG Sundal Collier
Carla Bänziger	Bank Vontobel AG
Sebastian Satz	Barclays

Novozymes A/SXTRA:NZM2 Stock Report